ADAMTS13 and hepatocellular carcinoma: In contrast to these findings, and demonstrating the need for further studies, ADAMTS13 activity was found to be significantly higher in those developing HCC in a separate study incorporating both chronic hepatitis and cirrhotic patients, and was independently associated with the risk of developing HCC [138].